Related Experiment Video

Updated: Aug 30, 2025

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.1K

Advances in cell death mechanisms involved in viral myocarditis

Yang Yang1,2, Wang Li1,2, Benshuai You3

  • 1Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, China.

Frontiers in Cardiovascular Medicine
|August 26, 2022
PubMed

Insights

Viral myocarditis, often caused by coxsackievirus B3, involves abnormal cardiomyocyte death. Understanding these cell death mechanisms, including those in SARS-CoV-2 infection, is key to developing effective treatments and improving heart health.

Area of Science:

  • Cardiology
  • Virology
  • Cell Biology

Background:

  • Viral myocarditis is an acute myocardial inflammatory disease.
  • Coxsackievirus B3 is a primary etiological factor.
  • Abnormal cardiomyocyte death underlies many cardiovascular diseases.

Purpose of the Study:

  • To review cell death mechanisms in viral myocarditis.
  • To explore interactions between different cell death pathways.
  • To investigate cardiomyocyte death in SARS-CoV-2 infection.

Main Methods:

  • Literature review of viral myocarditis.
  • Analysis of cell death pathways.
  • Examination of SARS-CoV-2's role in cardiomyocyte death.

Main Results:

  • Multiple cell death mechanisms are involved in viral myocarditis.
  • Interactions between these mechanisms are significant.
  • SARS-CoV-2 infection also induces cardiomyocyte death.

Conclusions:

  • Understanding cardiomyocyte death mechanisms is crucial for early diagnosis and treatment of viral myocarditis.
  • Inhibiting cardiomyocyte death offers significant therapeutic potential for heart health and longevity.
  • Further research into these mechanisms can improve patient quality of life.
Keywords:
CVB3SARS-CoV-2VMCapoptosisautophagyferroptosisnecrosispyroptosis

More Related Videos

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke11:32

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

1.1K
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.7K

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
23
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.6K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19